Commercialization Options Sample Clauses
The 'Commercialization Options' clause defines the available methods or strategies for bringing a product, technology, or intellectual property to market. It typically outlines whether the parties may pursue licensing, direct sales, joint ventures, or other forms of commercialization, and may specify the roles, rights, and obligations of each party in these processes. By clearly setting out the permitted commercialization pathways, this clause helps prevent disputes over how the subject matter can be exploited and ensures that both parties have a shared understanding of their options and limitations.
Commercialization Options. Employees who wish to Commercialize their Intellectual Property may:
(a) Make their own Commercialization arrangements, independent of the Employer at their own expense subject to the provisions contained in Articles 33.12(b) and 33.16(a), or;
(b) Request the Employer to Commercialize the Intellectual Property in which case Articles 33.15 and 33.16(b) shall apply.
Commercialization Options. Subject to the terms and conditions of this Agreement, on an Option Target-by-Option Target basis, effective solely upon the Research Option Exercise Date, Regulus hereby grants to Sanofi the nonexclusive, nontransferable right, exercisable in accordance with this ARTICLE 3, to obtain the exclusive licenses set forth in Section 3.5 below under the terms and conditions set forth in this Agreement (each a “Commercial Option”). For clarity, until Regulus grants Sanofi a Commercial License with respect to a particular Option Target, Regulus may collaborate with a Third Party (including granting a license) with respect to such Option Target, and any Commercial License Regulus later grants to Sanofi with respect to such Option Target will be subject to any rights Regulus granted to such Third Party prior to Sanofi’s exercise of the applicable Commercial Option. If after the Research Option Exercise Date, Sanofi reasonably believes that […***…] under either the […***…] or […***…] fall within the definition of Regulus Platform Technology Patents and cover a Option Product being developed by Sanofi, Regulus and Sanofi will negotiate in good faith and use commercially reasonable efforts to […***…] under the specific […***…] that cover the Option Product solely to Research, Develop, make, have made, use, gain Approval, Commercialize, sell, offer for sale, have sold, export and import the applicable Option Compounds and Option Products.